Gene · 9739
NIH grants1,845
NIH grants whose papers are about the gene, through NIH's grant-paper links.
381 to 400 of 1,845
Download this page as JSON| Grant | Title | SETD1A papers | Newest fiscal year |
|---|---|---|---|
| F30CA250254 | Role of SerpinB3 in glioblastoma cancer stem cells | 1 | 2024 |
| I01CX001364 | Type I Interferon Regulation of Tumor Cell and Immune Cell Interaction in Human Colon Cancer | 1 | 2024 |
| K00CA253768 | Sex Differences in Blood-Brain and Blood-Tumor Barrier Dynamics in Glioblastoma | 1 | 2024 |
| K22CA258805 | Targeted disruption of the YAP/TAZ/TEAD axis in pancreatic cancer | 1 | 2024 |
| K23HD101646 | Preparing for a Clinical Trial in Kabuki Syndrome- Characterization of Cognitive and Neuroanatomical Features and Pilot Treatment Trial | 1 | 2024 |
| P01AG049665 | Disordered Proteostasis as a Driver of Disease in the Aging Lung | 1 | 2024 |
| P01CA233452 | Determinants of Liver Metastasis | 1 | 2024 |
| P01CA236585 | Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma | 1 | 2024 |
| P20GM104320 | Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules | 1 | 2024 |
| P30AG038072 | Einstein's Nathan Shock Center of Excellence in Basic Biology of Aging | 1 | 2024 |
| P30EY002687 | Core Grant for Vision Research | 1 | 2024 |
| P50HD098593 | Center for Male Reproductive Epigenomics | 1 | 2024 |
| R01AG015819 | Risk Factors, Pathology, and Clinical Expressions of AD | 1 | 2024 |
| R01AG044346 | Mechanisms Specific to the Beneficial Effects of Dietary Restriction | 1 | 2024 |
| R01AG067106 | Reversing Loss of Metabolic Homeostasis to Ameliorate Alzheimer's Disease Pathogenicity | 1 | 2024 |
| R01AG067146 | Adipokines, Aging, and Alzheimers Disease | 1 | 2024 |
| R01AI114362 | Transcriptional regulatory mechanisms shaping HIV proviral fate | 1 | 2024 |
| R01AI141673 | Understanding the role of histone3 lysine4 trimethylation in neontal innate immune development under normal and inflammatory conditions | 1 | 2024 |
| R01AI149672 | Defining Mechanisms of Viral Persistence in Situ at the Single-Cell Level | 1 | 2024 |
| R01AI153396 | Chromatin dynamics in the regulation of herpes simplex virus 1 gene expression. | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9739/grants?page=20